What does Apotheek Leemans-Vanheusden do?

Apotheek Leemans-Vanheusden is a pharmacy in Bilzen-Hoeselt. Private Limited, started on 6 February 1995, 1 establishment.

What is the address of Apotheek Leemans-Vanheusden?

The registered office of Apotheek Leemans-Vanheusden is located at Markt 43, 3740 Bilzen-Hoeselt.

Is Apotheek Leemans-Vanheusden still active?

Yes. According to the CBE (30 October 2026) Apotheek Leemans-Vanheusden is active, legal situation “Normale toestand”, started on 6 February 1995.

Is Apotheek Leemans-Vanheusden registered on Peppol?

Yes, Apotheek Leemans-Vanheusden is registered on the Peppol network with ID 0208:0454490332.

What is the enterprise number of Apotheek Leemans-Vanheusden?

The enterprise number of Apotheek Leemans-Vanheusden is BE0454490332.

When was Apotheek Leemans-Vanheusden founded?

Apotheek Leemans-Vanheusden was founded on 6 February 1995.

Who are the directors of Apotheek Leemans-Vanheusden?

According to the 2025 annual accounts, the directors of Apotheek Leemans-Vanheusden are: VANHEUSDEN BV.

Is Apotheek Leemans-Vanheusden a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 February 1995; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Leemans-Vanheusden make in 2025?

Apotheek Leemans-Vanheusden posted a profit after taxes of € 320,016 in financial year 2025.

What is the revenue of Apotheek Leemans-Vanheusden?

As a small company, Apotheek Leemans-Vanheusden is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 526,078.

How much does an employee at Apotheek Leemans-Vanheusden earn?

The average wage cost per full-time employee at Apotheek Leemans-Vanheusden was € 54,300 in 2025: staff costs of € 54,339 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Leemans-Vanheusden have?

According to the 2025 annual accounts, Apotheek Leemans-Vanheusden has 1 full-time equivalents (FTE).

Apotheek Leemans-Vanheusden (Private Limited)

Dossier Apotheek Leemans-Vanheusden, printed on 30 October 2026 from databakkes.be/en/0454490332/apotheek-leemans-vanheusden. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 24 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek Leemans-Vanheusden from Bilzen-Hoeselt, company number BE0454490332, closed financial year 2025 with a result of € 320,016 after tax. For that financial year Apotheek Leemans-Vanheusden recorded a gross margin of € 526,078 and equity of € 61,239. Compared with financial year 2024, the result moved from € 109,719 to € 320,016. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Growing

€ 61,239

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 320,016

▲ 192% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 277,695

▼ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 320,000 paid out

100 % of the profit went to the shareholders, mostly to VANHEUSDEN (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 54,339

▲ 3% vs 2024

€ 54,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 38,928

▼ 14% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 670,000

▼ 14% vs 2024

€ 105,000 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 64,954

▲ 50% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,133

▼ 84% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 287,422 Gross margin 2022: € 287,422 First fiscal year in the series	€ 258,497 Gross margin 2023: € 258,497 ▼ 10% vs 2022 (€ 287,422) Unfavourable step	€ 300,665 Gross margin 2024: € 300,665 ▲ 16% vs 2023 (€ 258,497) Favourable step	€ 526,078 Gross margin 2025: € 526,078 ▲ 75% vs 2024 (€ 300,665) Favourable step	▲ 75%
Profit after taxes	€ 174,151 Profit after taxes 2022: € 174,151 First fiscal year in the series	€ 132,442 Profit after taxes 2023: € 132,442 ▼ 24% vs 2022 (€ 174,151) Unfavourable step	€ 109,719 Profit after taxes 2024: € 109,719 ▼ 17% vs 2023 (€ 132,442) Unfavourable step	€ 320,016 Profit after taxes 2025: € 320,016 ▲ 192% vs 2024 (€ 109,719) Favourable step	▲ 192%
Equity	€ 33,061 Equity 2022: € 33,061 First fiscal year in the series	€ 56,503 Equity 2023: € 56,503 ▲ 71% vs 2022 (€ 33,061) Favourable step	€ 61,222 Equity 2024: € 61,222 ▲ 8% vs 2023 (€ 56,503) Favourable step	€ 61,239 Equity 2025: € 61,239 Unchanged (€ 61,222) Favourable step
Total debts	€ 1,636,580 Total debts 2022: € 1,636,580 First fiscal year in the series	€ 2,196,620 Total debts 2023: € 2,196,620 ▲ 34% vs 2022 (€ 1,636,580) Unfavourable step	€ 2,787,688 Total debts 2024: € 2,787,688 ▲ 27% vs 2023 (€ 2,196,620) Unfavourable step	€ 2,275,759 Total debts 2025: € 2,275,759 ▼ 18% vs 2024 (€ 2,787,688) Favourable step	▼ 18%
Cash	€ 398,863 Cash 2022: € 398,863 First fiscal year in the series	€ 512,417 Cash 2023: € 512,417 ▲ 28% vs 2022 (€ 398,863) Favourable step	€ 286,893 Cash 2024: € 286,893 ▼ 44% vs 2023 (€ 512,417) Unfavourable step	€ 277,695 Cash 2025: € 277,695 ▼ 3% vs 2024 (€ 286,893) Unfavourable step	▼ 3%
Land & buildings	€ 1,046,139 Land & buildings 2022: € 1,046,139 First fiscal year in the series	€ 1,500,558 Land & buildings 2023: € 1,500,558 ▲ 43% vs 2022 (€ 1,046,139) Unchanged	€ 1,925,636 Land & buildings 2024: € 1,925,636 ▲ 28% vs 2023 (€ 1,500,558) Unchanged	€ 1,462,360 Land & buildings 2025: € 1,462,360 ▼ 24% vs 2024 (€ 1,925,636) Unchanged	▼ 24%
Retained profit	€ 26,864 Retained profit 2022: € 26,864 First fiscal year in the series	€ 50,305 Retained profit 2023: € 50,305 ▲ 87% vs 2022 (€ 26,864) Favourable step	€ 55,025 Retained profit 2024: € 55,025 ▲ 9% vs 2023 (€ 50,305) Favourable step	€ 55,041 Retained profit 2025: € 55,041 Unchanged (€ 55,025) Favourable step
Dividend	€ 174,000 Dividend 2022: € 174,000 First fiscal year in the series	€ 109,000 Dividend 2023: € 109,000 ▼ 37% vs 2022 (€ 174,000) Unchanged	€ 105,000 Dividend 2024: € 105,000 ▼ 4% vs 2023 (€ 109,000) Unchanged	€ 320,000 Dividend 2025: € 320,000 ▲ 205% vs 2024 (€ 105,000) Unchanged	▲ 205%
Bank debt	€ 476,667 Bank debt 2022: € 476,667 First fiscal year in the series	€ 880,000 Bank debt 2023: € 880,000 ▲ 85% vs 2022 (€ 476,667) Unfavourable step	€ 775,000 Bank debt 2024: € 775,000 ▼ 12% vs 2023 (€ 880,000) Favourable step	€ 670,000 Bank debt 2025: € 670,000 ▼ 14% vs 2024 (€ 775,000) Favourable step	▼ 14%
Balance sheet total	€ 1,669,642 Balance sheet total 2022: € 1,669,642 First fiscal year in the series	€ 2,253,123 Balance sheet total 2023: € 2,253,123 ▲ 35% vs 2022 (€ 1,669,642) Unchanged	€ 2,848,911 Balance sheet total 2024: € 2,848,911 ▲ 26% vs 2023 (€ 2,253,123) Unchanged	€ 2,336,998 Balance sheet total 2025: € 2,336,998 ▼ 18% vs 2024 (€ 2,848,911) Unchanged	▼ 18%
Employees (FTE)	-	1 Employees (FTE) 2023: 1 First fiscal year in the series	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of Apotheek Leemans-Vanheusden, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Leemans-Vanheusden?

What happened at Apotheek Leemans-Vanheusden in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 320,016 (▲ 192% vs 2024). Source: NBB ↗
2014 VANHEUSDEN BV became a director. NBB
Apr 28, 1995 New establishment in Bilzen-Hoeselt. KBO
Feb 6, 1995 Start of the company according to the CBE. KBO

In short

From € 174,151 profit in 2022 to € 320,016 profit in 2025.

Paid € 18,344 in corporate taxes since 2022.

Best year ever: 2025, with € 320,016 profit.

On average € 526,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

VANHEUSDEN 100%

The stake of VANHEUSDEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Leemans-Vanheusden

Behind Apotheek Leemans-Vanheusden is VANHEUSDEN BV. The shares are held by VANHEUSDEN (100%).

Directors

According to the 2025 annual accounts

VANHEUSDEN BV

Director · represented by Dirk Vanheusden

Also active at: APOTEEK VANHEUSDEN

since 2014

Shareholders

VANHEUSDEN

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Markt 43

3740 Bilzen-Hoeselt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0454.490.332

VAT number

BE 0454.490.332

Registered office

Markt 43, 3740 Bilzen-Hoeselt

Names & denominations

Apotheek Leemans-Vanheusden

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 February 1995

Peppol

Active · Active since 16 Jul 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Leemans-Vanheusden

Warning lights

Financials

What happened to Apotheek Leemans-Vanheusden?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions